#USA #Charlotte #Dechert LLP #Healthcare Law #Jennifer Hutchens

Dechert Strengthens Healthcare Practice with New Partner

Dechert LLP, a prominent global law firm, has announced a significant addition to its healthcare and life sciences team by welcoming Jennifer Csik Hutchens as a partner in its corporate and securities practice. This strategic move aims to enhance the firm's capabilities in healthcare transactions and regulatory guidance, reflecting Dechert's ongoing commitment to serve clients in these critical sectors.

Jennifer Csik Hutchens brings a wealth of experience in healthcare and life sciences, focusing primarily on regulatory matters and transactional work. She will be leading Dechert's healthcare regulatory practice and play a pivotal role in the firm’s cross-practice group healthcare initiatives. Based in the Charlotte office, she is set to strengthen the firm's presence in the healthcare sector significantly.

Mark Thierfelder, co-chair of Dechert, expressed enthusiasm about Ms. Hutchens joining the firm. He highlighted her extensive experience, particularly in advising private equity and other strategic clients, stating that her expertise aligns seamlessly with Dechert's strategic goals of deepening client engagement in the healthcare and life sciences fields.

Ken Young, co-chair of the corporate and securities practice, also welcomed her, underlining the value of her client-centric approach and her ability to navigate complex regulatory environments. He emphasized that her skills will be particularly beneficial for private equity and clients looking to implement innovative solutions and conduct first-of-their-kind transactions.

Prior to joining Dechert, Hutchens served as the global head of healthcare and life sciences at an international law firm. Her legal career began with a Charlotte-based firm, where she quickly rose to the position of partner and co-chair of its healthcare practice. Her broad transactional experience encompasses joint ventures, mergers and acquisitions, healthcare contracting, and various collaborative transactions. Furthermore, her regulatory practice focuses heavily on navigating intricate healthcare laws and providing inclusive compliance advice. She has advised a diverse range of clients, from hospitals and healthcare corporations to private equity-backed funds and institutional investors.

Hutchens commented on her new role saying, "Dechert's strategic direction and leading platform provide the perfect environment for me to elevate my practice and best serve my clients. I am excited about the opportunities to further develop an industry-leading healthcare practice at Dechert and contribute to the firm’s growth in this space."

She is a summa cum laude graduate of both Duke University and Duke University School of Law and has been recognized by Best Lawyers of America in healthcare law since 2015. Chambers USA has ranked her Band 2 in healthcare in North Carolina since 2018. Additionally, Hutchens serves on the Board of Directors for the American Health Law Association (AHLA), contributing to the finance committee as well.

With more than 40 years of experience advising private equity firms, Dechert is recognized among the leading law firms in the U.S. and globally for private equity buyouts and mergers and acquisitions. The firm represents over 350 private equity and investment clients, providing insights into industry evolution and future direction. Dechert’s team assists private equity, private credit, and other alternative asset managers at every phase of the investment life cycle, offering flexible solutions tailored to their needs.

The firm's life sciences group combines industry expertise with commercial judgment to aid leading organizations in handling their most challenging transactions, intellectual property, and litigation issues. With a multidisciplinary team that spans global resources, Dechert stands ready to support clients through comprehensive transactional, regulatory, and dispute resolution services anywhere in the world.

Dechert LLP is a global law firm dedicated to advising asset managers, financial institutions, and corporations on issues critical to business management and capital growth, ranging from complex transactions to high-stakes litigation and regulatory challenges. With nearly 1,000 attorneys across 19 offices worldwide, the firm specializes in sectors like financial services, private equity, private credit, real estate, technology, and life sciences.